Skip Nav Destination
Venetoclax: a primer
Issue Archive
February 28 2017
Table of Contents
BLOOD ADVANCES TALK
Venetoclax: a primer
Clinical Trials & Observations
LYMPHOID NEOPLASIA
Cardiac and renal complications of carfilzomib in patients with multiple myeloma
Meletios A. Dimopoulos,Maria Roussou,Maria Gavriatopoulou,Erasmia Psimenou,Dimitrios Ziogas,Evangelos Eleutherakis-Papaiakovou,Despina Fotiou,Magdalini Migkou,Nikolaos Kanellias,Ioannis Panagiotidis,Argyrios Ntalianis,Elektra Papadopoulou,Kimon Stamatelopoulos,Efstathios Manios,Constantinos Pamboukas,Sofoklis Kontogiannis,Evangelos Terpos,Efstathios Kastritis
MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
TRANSPLANTATION
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1
Jurjen Versluis,Myriam Labopin,Annalisa Ruggeri,Gerard Socie,Depei Wu,Liisa Volin,Didier Blaise,Noel Milpied,Charles Craddock,Ibrahim Yakoub-Agha,Johan Maertens,Per Ljungman,Anne Huynh,Mauricette Michallet,Eric Deconinck,Patrice Chevallier,Jakob Passweg,Fabio Ciceri,Mohamad Mohty,Jan J. Cornelissen,Arnon Nagler,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
VASCULAR BIOLOGY
-
Cover Image
Cover Image
COVER FIGURE
Snapshot at 230 ns from molecular dynamics simulations of a representative structure of αIIbβ3 headpiece-fibrinogen γ-module complex showing a relaxed model of fibrinogen γ-module binding to αIIbβ3. Fibrinogen, αIIb, and β3 are colored gray, blue, and red, respectively. The last 7 amino acids of the fibrinogen γ-chain are colored yellow. See the article by Zafar et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals